Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_4

29%

Ph not_applicable

57%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 4Post-market surveillance

2(33.3%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(3)

Detailed Status

unknown3

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 42 (33.3%)

N/A4 (66.7%)

Trials by Status

unknown343%

completed343%

terminated114%

Recent Activity

0 active trials

Showing 5 of 7

unknownnot_applicable

The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants

NCT04508257

unknownnot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT04508257Not Applicable

The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants

Unknown

NCT04013087Not Applicable

Safety and Nutritional Adequacy of a New Infant Formula in Healthy Term Infants

Unknown

NCT02999165

Breastfeeding Infants Receiving Respiratory Support Trial

Terminated

NCT01276366Not Applicable

Amphia Premature Infant Pain Study

Completed

NCT03684499Not Applicable

Fluid in Neonatal Hyperbilirubinemia

Unknown

NCT01157390Phase 4

Tolerance and Efficacy of Wondersun Infant Formula in Formula-fed Chinese Term Infants

Completed

NCT02406937Phase 4

New Stage 1 Formula on Gut Comfort and Gut Health

Completed

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7